149 related articles for article (PubMed ID: 37327957)
21. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial.
Bengtsson B; Leske MC; Hyman L; Heijl A;
Ophthalmology; 2007 Feb; 114(2):205-9. PubMed ID: 17097736
[TBL] [Abstract][Full Text] [Related]
22. Visual field and intraocular pressure asymmetry in the low-pressure glaucoma treatment study.
Greenfield DS; Liebmann JM; Ritch R; Krupin T;
Ophthalmology; 2007 Mar; 114(3):460-5. PubMed ID: 17141318
[TBL] [Abstract][Full Text] [Related]
23. Beta-Zone parapapillary atrophy and the velocity of glaucoma progression.
Teng CC; De Moraes CG; Prata TS; Tello C; Ritch R; Liebmann JM
Ophthalmology; 2010 May; 117(5):909-15. PubMed ID: 20132988
[TBL] [Abstract][Full Text] [Related]
24. Investigation of intraocular pressure fluctuation as a risk factor of glaucoma progression.
Matlach J; Bender S; König J; Binder H; Pfeiffer N; Hoffmann EM
Clin Ophthalmol; 2019; 13():9-16. PubMed ID: 30587914
[TBL] [Abstract][Full Text] [Related]
25. Intraocular pressure control and visual field changes in primary angle closure disease: the CUHK PACG Longitudinal (CUPAL) study.
Cheung CY; Li SL; Chan PP; Chan NCY; Tan S; Man X; Tham CC
Br J Ophthalmol; 2020 May; 104(5):629-635. PubMed ID: 31391182
[TBL] [Abstract][Full Text] [Related]
26. Characteristics of visual field progression in medically treated normal-tension glaucoma patients with unstable ocular perfusion pressure.
Sung KR; Cho JW; Lee S; Yun SC; Choi J; Na JH; Lee Y; Kook MS
Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):737-43. PubMed ID: 20861474
[TBL] [Abstract][Full Text] [Related]
27. Factors associated with the presence of parafoveal scotoma in glaucomatous eyes with optic disc hemorrhages.
Dias DT; Almeida I; Sassaki AM; Juncal VR; Ushida M; Lopes FS; Alhadeff P; Ritch R; Prata TS
Eye (Lond); 2018 Oct; 32(10):1669-1674. PubMed ID: 29973693
[TBL] [Abstract][Full Text] [Related]
28. Risk Factors for Fast Visual Field Progression in Glaucoma.
Kim JH; Rabiolo A; Morales E; Yu F; Afifi AA; Nouri-Mahdavi K; Caprioli J
Am J Ophthalmol; 2019 Nov; 207():268-278. PubMed ID: 31238025
[TBL] [Abstract][Full Text] [Related]
29. The African Descent and Glaucoma Evaluation Study (ADAGES): predictors of visual field damage in glaucoma suspects.
Khachatryan N; Medeiros FA; Sharpsten L; Bowd C; Sample PA; Liebmann JM; Girkin CA; Weinreb RN; Miki A; Hammel N; Zangwill LM
Am J Ophthalmol; 2015 Apr; 159(4):777-87. PubMed ID: 25597839
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of visual field changes with retinal nerve fiber layer thickness in primary congenital glaucoma.
Naik A; Sihota R; Mahalingam K; Angmo D; Dada T; Kumar A; Kumar A; Gupta A
Indian J Ophthalmol; 2022 Oct; 70(10):3556-3561. PubMed ID: 36190046
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for visual field progression in the groningen longitudinal glaucoma study: a comparison of different statistical approaches.
Wesselink C; Marcus MW; Jansonius NM
J Glaucoma; 2012 Dec; 21(9):579-85. PubMed ID: 21701396
[TBL] [Abstract][Full Text] [Related]
32. Glaucoma Progression in the Unaffected Fellow Eye of Glaucoma Patients Who Developed Unilateral Branch Retinal Vein Occlusion.
Lopilly Park HY; Jeon S; Lee MY; Park CK
Am J Ophthalmol; 2017 Mar; 175():194-200. PubMed ID: 27793602
[TBL] [Abstract][Full Text] [Related]
33. Association Between Parapapillary Choroidal Vessel Density Measured With Optical Coherence Tomography Angiography and Future Visual Field Progression in Patients With Glaucoma.
Park HY; Shin DY; Jeon SJ; Park CK
JAMA Ophthalmol; 2019 Jun; 137(6):681-688. PubMed ID: 30920599
[TBL] [Abstract][Full Text] [Related]
34. The United Kingdom Glaucoma Treatment Study: a multicenter, randomized, double-masked, placebo-controlled trial: baseline characteristics.
Lascaratos G; Garway-Heath DF; Burton R; Bunce C; Xing W; Crabb DP; Russell RA; Shah A;
Ophthalmology; 2013 Dec; 120(12):2540-2545. PubMed ID: 24126032
[TBL] [Abstract][Full Text] [Related]
35. Glaucomatous Progression After Lens Extraction in Primary Angle Closure Disease Spectrum.
Song MK; Sung KR; Shin JW; Jo YH; Won HJ
J Glaucoma; 2020 Aug; 29(8):711-717. PubMed ID: 32366776
[TBL] [Abstract][Full Text] [Related]
36. Relationship between Intraocular Pressure Fluctuation and Visual Field Progression Rates in the United Kingdom Glaucoma Treatment Study.
Rabiolo A; Montesano G; Crabb DP; Garway-Heath DF;
Ophthalmology; 2024 Feb; ():. PubMed ID: 38354911
[TBL] [Abstract][Full Text] [Related]
37. Optic disc and visual field changes after trabeculectomy.
Kotecha A; Spratt A; Bunce C; Garway-Heath DF; Khaw PT; Viswanathan A;
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4693-9. PubMed ID: 19474409
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for disease progression in low-teens normal-tension glaucoma.
Baek SU; Ha A; Kim DW; Jeoung JW; Park KH; Kim YK
Br J Ophthalmol; 2020 Jan; 104(1):81-86. PubMed ID: 31055450
[TBL] [Abstract][Full Text] [Related]
39. Frequency-doubling technology perimetry for detection of the development of visual field defects in glaucoma suspect eyes: a prospective study.
Liu S; Yu M; Weinreb RN; Lai G; Lam DS; Leung CK
JAMA Ophthalmol; 2014 Jan; 132(1):77-83. PubMed ID: 24177945
[TBL] [Abstract][Full Text] [Related]
40. Correlation between 24-h continuous intraocular pressure measurement with a contact lens sensor and visual field progression.
Tojo N; Hayashi A; Otsuka M
Graefes Arch Clin Exp Ophthalmol; 2020 Jan; 258(1):175-182. PubMed ID: 31659459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
